An innovative fridge-free vaccine will enter its first-in-human clinical trial at the National Institute for Health and Care Research (NIHR) Southampton Clinical Research Facility.
Barney Reed, Senior Scientific Manager, Animals in Science Department at the RSPCA, stresses the need for ambitious strategies for phasing out the use of animals in science.
Monica Racoviță, Senior Researcher at The Health Policy Partnership, argues that opioid dependence is a pressing issue, yet treatment for it is still out of reach for many.
In a surprising turn of events, Prince Harry's public endorsement of the transformative power of psychedelic therapy has triggered a psychedelic resurgence in the UK.
Could cannabis for cancer become a reality in patient wards? Researchers find the plant can improve sleep, pain, and brain clarity, easing 'chemo brain'.
The effect of the anti-ageing drug rapamycin differs in male and female fruit flies, find researchers, who seek to understand how sex influences the development of age-related disease.
The ‘entourage effect’ of cannabis comes from the pain-relieving effects of the plant, but could we boost this pain-relieving efficacy of THC without the psychoactive side effects?
David Nutt FMedSci, Chair Drug Science and PAREA, Prof of Neuropsychopharmacology at Imperial College London, explains why Europe needs to catch up with psychedelic research.
Researchers discover drug combination that could offer a better prognosis for children diagnosed with MYC amplified Medulloblastoma, an often deadly form of brain cancer.
Despite the rising incidence of Central Nervous System diseases worldwide, efficient treatment options for neurological disorders remain scarce. Treatment failures are principally associated with the inability of drugs to pass the highly selective Blood-Brain Barrier rather than a lack of efficacy.
